Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 8, 2015, Pages 1174-1183

  Sisti, Julia S ^a   Hankinson, Susan E ^a,b,c   Caporaso, Neil E ^d   Gu, Fangyi ^d   Tamimi, Rulla M ^a,b   Rosner, Bernard ^b   Xu, Xia ^e   Ziegler, Regina ^d   Eliassen, A Heather ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16 EPIESTRIOL; 16 KETOESTRADIOL; 16ALPHA HYDROXYESTRONE; 17 EPIESTRIOL; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; 2 HYDROXYESTRONE 3 METHYL ETHER; 2 METHOXYESTRADIOL; 2 METHOXYESTRONE; 4 HYDROXYESTRONE; 4 METHOXYESTRADIOL; 4 METHOXYESTRONE; CAFFEINE; CATECHOL DERIVATIVE; CREATININE; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRIOL; ESTROGEN; ESTRONE; SEX HORMONE; UNCLASSIFIED DRUG; COFFEE; TEA;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; COFFEE; CONTROLLED STUDY; CREATININE URINE LEVEL; ESTROGEN METABOLISM; ESTROGEN URINE LEVEL; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE METABOLISM; HUMAN; HYDROXYLATION; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; METABOLITE; PHYSICAL ACTIVITY; PREMENOPAUSE; PRIORITY JOURNAL; SELF REPORT; TANDEM MASS SPECTROMETRY; TEA; URINALYSIS; CHEMISTRY; COHORT ANALYSIS; LIQUID CHROMATOGRAPHY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; URINE;

ADULT; CAFFEINE; CHROMATOGRAPHY, LIQUID; COFFEE; COHORT STUDIES; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; PREMENOPAUSE; PROSPECTIVE STUDIES; TANDEM MASS SPECTROMETRY; TEA;

EID: 84941787886     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0246     Document Type: Article

References (44)

1. Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez-Garcia E, et al. Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 2008;122:2071-6.
2. Li J, Seibold P, Chang-Claude J, Flesch-Janys D, Liu J, Czene K, et al. Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Res 2011;13:R49.
3. Boggs DA, Palmer JR, Stampfer MJ, Spiegelman D, Adams-Campbell LL, Rosenberg L. Tea and coffee intake in relation to risk of breast cancer in the Black Women's Health Study. Cancer Causes Control 2010;21: 1941-8.
4. Gierach GL, Freedman ND, Andaya A, Hollenbeck AR, Park Y, Schatzkin A, et al. Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort. Int J Cancer 2012;131:452-60.
5. Ishitani K, Lin J, Manson JE, Buring JE, Zhang SM. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 2008;168:2022-31.
6. Larsson SC, Bergkvist L, Wolk A. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Causes Control 2009;20:2039-44.
7. Tang N, Zhou B, Wang B, Yu R. Coffee consumption and risk of breast cancer: a metaanalysis. Am J Obstet Gynecol 2009;200:290. e1-9.
8. JiangW,Wu Y, Jiang X. Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies. Gynecol Oncol 2013;129:620-9.
9. Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J. Metaanalyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 2010;92:141-53.
10. Mense SM, Hei TK, Ganju RK, Bhat HK. Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect 2008;116:426-33.
11. Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003;144:3382-98.
12. Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF. Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and Noxidation of carcinogenic arylamines. Proc Natl Acad Sci U S A 1989; 86:7696-700.
13. Yue W, Yager JD, Wang J-P, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids 2013;78:161-70.
14. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monographs 2000:75-93.
15. Lippert C, Seeger H, Mueck AO. The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci 2003;72:877-83.
16. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84:634-8.
17. Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, et al. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 2012;72: 696-706.
18. Bageman E, Ingvar C, Rose C, Jernström H. Coffee consumption and CYP1A2-1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev 2008;17: 895-901.
19. Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, et al. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 2007;16:912-6.
20. Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS. Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 2009;115:2765-74.
21. Jernström H, Klug TL, Sepkovic DW, Bradlow HL, Narod SA. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis 2003;24:991-1005.
22. Eliassen AH, Ziegler RG, Rosner B, Veenstra TD, Roman JM, Xu X, et al. Reproducibility of fifteen urinary estrogens and estrogenmetabolites over a 2-to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2009;18:2860-8.
23. Willett WC. Nutritional epidemiology. New York: Oxford University Press; 1998.
24. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2-to 3-year period. Cancer Epidemiol Biomarkers Prev 2006;15:972-8.
25. Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Breast Cancer Res 2013;15: R19.
26. Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, et al. Measuring fifteen endogenous estrogens simultaneously in human urine by highperformance liquid chromatography-mass spectrometry. Anal Chem 2005;77:6646-54.
27. Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG. A liquid chromatographymass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 2008;17: 3411-8.
28. Rosner B. Percentage points for a generalized ESD many-outlier procedure. Technometrics 1983;25:165-72.
29. Bradlow HL, Jernström H, Sepkovic DW, Klug TL, Narod SA. Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites. Mol Genet Metab 2006;87: 135-46.
30. Sowers MR, Crawford S, McConnell DS, Randolph JF Jr, Gold EB, Wilkin MK, et al. Selected diet and lifestyle factors are associated with estrogen metabolites in a multiracial/ethnic population of women. J Nutr 2006;136: 1588-95.
31. Tantcheva-Poor I, ZaiglerM, Rietbrock S, Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 1999;9:131-44.
32. Djordjevic N, Ghotbi R, Bertilsson L, Jankovic S, Aklillu E. Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes. Eur J Clin Pharmacol 2008;64:381-5.
33. Vakharia DD, Liu N, Pause R, Fasco M, Bessette E, Zhang QY, et al. Effect of metals on polycyclic aromatic hydrocarbon induction of CYP1A1 and CYP1A2 in human hepatocyte cultures. Toxicol Appl Pharmacol 2001;170: 93-103.
34. Zhu BT, Wang P, Nagai M, Wen Y, Bai H-W. Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee. J Steroid Biochem Mol Biol 2009;113:65-74.
35. Alves RC, Costa ASG, Jerez M, Casal S, Sineiro J,Nuñez MJ, et al. Antiradical activity, phenolics profile, and hydroxymethylfurfural in espresso coffee: influence of technological factors. J Agric Food Chem 2010;58:12221-9.
36. Farah A, de Paulis T, Moreira DP, Trugo LC, Martin PR. Chlorogenic acids and lactones in regular and water-decaffeinated arabica coffees. J Agric Food Chem 2006;54:374-81.
37. Seeger H, Wallwiener D, Kraemer E, Mueck AO. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 2006;54:72-7.
38. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J. Estradiol 16 alphahydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A 1985;82:6295-9.
39. Zhu BT, Conney AH. Functional role of estrogenmetabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1-27.
40. Liu Z-J, Zhu BT. Concentration-dependentmitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J Steroid Biochem Mol Biol 2004;88:265-75.
41. Gu F, Caporaso NE, Schairer C, Fortner RT, Xu X, Hankinson SE, et al. Urinary concentrations of estrogens and estrogenmetabolites and smoking in caucasian women. Cancer Epidemiol Biomarkers Prev 2013;22:58-68.
42. Schliep KC, Schisterman EF, Mumford SL, Perkins NJ, Ye A, Pollack AZ, et al. Validation of different instruments for caffeine measurement among premenopausal women in the BioCycle study. Am J Epidemiol 2013;177: 690-9.
43. Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, et al. Caffeinated and caffeine-free beverages and risk of type 2 diabetes.Am J Clin Nutr 2013;97:155-66.
44. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Colditz GA, Speizer FE, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001;50:56-63.